| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Sofinnova Venture Partners X, L.P. is a 10% Owner at JBIO, with reported holdings spanning 3 companies. Recent filings cover 5 purchases and 0 sales. Those positions are worth an estimated $207.7M at current prices.
Our model assigns Sofinnova Venture Partners X, L.P. a middling insider score of 55/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +14.9%.
Sofinnova Venture Partners X, L.P.'s largest disclosed position is in VERA as 10% Owner, worth about $114.0M. Net of sales, the recent Form 4 record there shows accumulation of 1,279,652 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2023 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 285,714 | $7.00 | $1,999,998.00 | +9.0% | +8.5% | +445.9% | |
| Feb 10, 2022 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 266,666 | $15.00 | $3,999,990.00 | +9.1% | -14.9% | -58.0% | |
| Jul 2, 2021 | JBIO Jade Biosciences, Inc. | 10% Owner | Buy | 357,142 | $14.00 | $4,999,988.00 | +10.5% | +5.2% | -15.1% | |
| May 18, 2021 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | +33.2% | +37.7% | +32.9% | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | 10% Owner | Buy | 450,000 | $20.00 | $9,000,000.00 | +19.5% | - | - |